Abstract
Scientific and medical evidence over the past 30 years has established striking parallels between atherosclerosis and cancer—pathogenetic relationships that cross the boundaries of fiction into the realm of reason. Both diseases in humans are characterized by uncontrolled regulation of cellular growth and differentiation and share many common genomic targets during the course of growth dysregulation. Such parallels can be reconciled if atherosclerotic plaques are viewed as neoplasms of smooth muscle origin.
Similar content being viewed by others
References
American Heart Association. (2005). Heart Disease and Stroke Statistics—2005 Update, American Heart Association, Dallas, TX.
Hansen, E.S. (1990). International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/2. Shared risk factors for cancer and atherosclerosis—a review of the epidemiological evidence. Mutat. Res. 239:163–179.
Chang, M.Y., Sasahara, M., Chait, A., Raines, E.W., and Ross, R. (1995). Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation. Arterioscler. Thromb. Vasc. Biol. 15:1631–1640.
Ambrose, J.A. and Barua, R.S. (2004). The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43:1731–1737.
Cooke, J.P. and Bitterman, H. (2004). Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann. Med. 36:33–40.
Bartsch, H., Petruzzelli, S., De Flora, S., Hietanen, E., Camus, A.M., Castegnaro, M., et al. (1991). Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients. Mutat. Res. 250:103–114.
Maxwell, S.R. (1998). Women and heart disease. Basic Res. Cardiol. 93(Suppl. 2):79–84.
Dubey, R.K., Imthurn, B., Barton, M., and Jackson, E.K. (2005). Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 66:295–306.
Vogelvang, T.E., van der Mooren, M.J., and Mijatovic, V. (2004). Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications. Treat. Endocrinol. 3:105–115.
Slater, S. and Oliver, R.T. (2000). Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy. Drugs Aging 17:431–439.
Wick, G., Berger, P., Jansen-Durr, P., and Grubeck-Loebenstein, B. (2003). A Darwinian-evolutionary concept of age-related diseases. Exp. Gerontol. 38:13–25.
Wick, G., Jansen-Durr, P., Berger, P., Blasko, I., and Grubeck-Loebenstein, B. (2000). Diseases of aging. Vaccine 18:1567–1583.
Swynghedauw, B. (2004). Evolutionary medicine. Acta Chir. Belg. 104:132–139.
Knoflach, M., Mayrl, B., Mayerl, C., Sedivy, R., and Wick, G. (2003). Atherosclerosis as a paradigmatic disease of the elderly: role of the immune system. Immunol. Allergy Clin. North Am. 23:117–132.
Klaunig, J.E. and Kamendulis, L.M. (2004). The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. toxicol. 44:239–267.
Olinski, R., Gackowski, D., Foksinski, M., Rozalski, R., Roszkowski, K., and Jaruga, P. (2002). Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic. Biol. Med. 33:192–200.
Zarubin, T. and Han, J. (2005). Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15:11–18.
Lim, M.Y., Wang, H., Kapoun, A.M., O'Connell, M., O'Young, G., Brauer, H.A., et al. (2004). p38 inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells. J. Mol. Cell. Cardiol. 37:1111–1114.
Ross, R. (1999). Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340:115–126.
Morganti, M., Carpi, A., Nicolini, A., Gorini, I., Glaviano, B., Fini, M., et al. (2002). Atherosclerosis and cancer: common pathways on the vascular endothelium. Biomed. Pharmacother. 56:317–324.
Ross, J.S., Stagliano, N.E., Donovan, M.J., Breitbart, R.E., and Ginsburg, G.S. (2001). Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann. NY Acad. Sci. 947:271–292; discussion 292–293.
Hu, H., Pierce, G.N., and Zhong, G. (1999). The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Invest. 103:747–753.
Espinola-Klein, C., Rupprecht, H.J., Blankenberg, S., Bickel, C., Kopp, H., Victor, A., et al. (2002). Impact of infectious burden on progression of carotid atherosclerosis. Stroke 33:2581–2586.
Partridge, C.R., Hawker, J.R. Jr., and Forough, R. (2000). Overexpression of a secretory form of FGF-1 promotes MMP-1-mediated endothelial cell migration. J. Cell. Biochem. 78 487–499.
Schneider, B.P. and Miller, K.D. (2005). Angiogenesis of breast cancer. J. Clin. Oncol. 23:1782–1790.
Folkman, J. and Shing, Y. (1992). Angiogenesis. J. Biol. Chem. 267 10931–10934.
Moulton, K.S., Vakili, K., Zurakowski, D., Soliman, M., Butterfield, C., Sylvin, E., et al. (2003). Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. USA 100:4736–4741.
Chen, G., Heilbrun, L.K., Venkatramanamoorthy, R., Maranci, V., Redd, J.N., Klurfeld, D.M., et al. (2004). Effects of low-fat and/or high-fruit-and-vegetable diets on plasma levels of 8-isoprostane-F2alpha in the Nutrition and Breast Health study. Nutr. Cancer 50:155–160.
Benditt, E.P. and Benditt, J.M. (1973). Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA 70:1753–1756.
Blaes, N. and Covacho, C. (1994). Transformed rat arterial smooth muscle cells induce platelet aggregation. Atherosclerosis 110:163–174.
Blaes, N., Bourdillon, M.C., Daniel-Lamaziere, J.M., Michaille, J.J., Andujar, M., and Covacho, C. (1991). Isolation of two morphologically distinct cell lines from rat arterial smooth muscle expressing high tumorigenic potentials. In Vitro Cell. Dev. Biol. 27A:725–734.
Schwartz, S.M. and Murry, C.E. (1998). Proliferation and the monoclonal origins of atherosclerotic lesions. Annu. Rev. Med. 49:437–460.
Ramos, K.S. (1999). Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: implications in chemical atherogenesis. Annu. Rev. Pharmacol. Toxicol. 39:243–265.
Albert, R.E., Vanderlaan, M., Burns, F.J., and Nishizumi, M. (1977). Effect of carcinogens on chicken atherosclerosis. Cancer Res. 37(7 Pt 1):2232–2235.
Bond, J.A., Gown, A.M., Yang, H.L., Benditt, E.P., and Juchau, M.R. (1981). Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J. Toxicol. Environ. Health 7:327–335.
Penn, A. and Snyder, C. (1988). Arteriosclerotic plaque development is ‘promoted’ by polynuclear aromatic hydrocarbons. Carcinogenesis 9:2185–2189.
Bond, J.A., Yang, H.Y., Majesky, M.W., Benditt, E.P., and Juchau, M.R. (1980). Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in chicken aortas: monooxygenation, bioactivation to mutagens, and covalent binding to DNA in vitro. Toxicol. Appl. Pharmacol. 52: 323–335.
Juchau, M.R., Bond, J.A., and Benditt, E.P. (1976). Aryl 4-monooxygenase and cytochrome P-450 in the aorta: possible role in atherosclerosis. Proc. Natl. Acad. Sci. USA 73:3723–3725.
Bond, J.A., Oiecinski, C.J., and Juchau, M.R. (1979). Kinetics, activation, and induction of aortic mono-oxygenases—biotransformation of benzo[a]pyrene. Biochem. Pharmacol. 28:305–311.
Paigen, B., Holmes, P.A., Morrow, A., and Mitchell, D. (1986). Effect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors. Cancer Res. 46:3321–3324.
Carlson, D.B. and Perdew, G.H. (2002). A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J. Biochem. Mol. Toxicol. 16:317–325.
Carver, L.A. and Bradfield, C.A. (1997). Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J. Biol. Chem. 272: 11452–11456.
Paigen, B., Holmes, P.A., Morrow, A., and Mitchell, D. (1986). Effect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors. Cancer Res. 46:3321–3324.
Baralle, M., Vergnes, L., Muro, A.F., Zakin, M.M., Baralle, F.E., and Ochoa, A. (1999). Regulation of the human apolipoprotein AIV gene expression in transgenic mice. FEBS Lett. 445:45–52.
Reddick, R.L., Zhang, S.H., and Maeda, N. (1994). Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler. Thromb. 14: 141–147.
Nakashima, Y., Plump, A.S., Raines, E.W., Breslow, J.L., and Ross, R. (1994). ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:133–140.
Curfs, D.M., Lutgens, E., Gijbels, M.J., Kockx, M.M., Daemen, M.J., and van Schooten, F.J. (2004). Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. Am. J. Pathol. 164:101–108.
Ross, R., Masuda, J., Raines, E.W., Gown, A.M., Katsuda, S., Sasahara, M., et al. (1990). Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 248:1009–1012.
Barrett, T.B. and Benditt, E.P. (1987). sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc. Natl. Acad. Sci. USA 84:1099–1103.
O'Donnell, K.A., Condon, M.E., and Hamburger, A.W. (1989). Production of platelet-derived growth factorlike protein(s) by a human carcinoma cell line. In Vitro Cell. Dev. Biol. 25:381–384.
Bejcek, B.E., Li, D.Y., and Deuel, T.F. (1989). Transformation by v-sis occurs by an internal autoactivation mechanism. Science 245:1496–1499.
Simons, M. and Rosenberg, R.D. (1992). Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ. Res. 70:835–843.
Nakagoshi, H., Kanei-Ishii, C., Sawazaki, T., Mizuguchi, G., and Ishii, S. (1992). Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7:1233–1240.
Edelman, E.R., Simons, M., Sirois, M.G., and Rosenberg, R.D. (1995). c-myc in vasculoproliferative disease. Circ. Res. 76:176–182.
Miano, J.M., Vlasic, N., Tota, R.R., and Stemerman, M.B. (1993). Localization of Fos and Jun proteins in rat aortic smooth muscle cells after vascular injury. Am. J. Pathol. 142:715–724.
Ramos, K.S., Zhang, Y., Sadhu, D.N., and Chapkin, R.C. (1996). The induction of proliferative phenotypes in vascular smooth muscle cells by benzo[a]pyrene is characterized by upregulation of phosphatidylinositol metabolism and c-Ha-ras gene expression. Arch. Biochem. Biophys. 332:213–222.
Sadhu, D.N., Lundberg, M.S., Burghardt, R.C., and Ramos, K.S. (1994). c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth, factor responsiveness and characteristics of a malignant phenotype. J. Cell. Physiol. 161:490–500.
Sadhu, D.N., Merchant, M., Safe, S.H., and Ramos, K.S. (1993). Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo[a]pyrene. Arch. Biochem. Biophys. 300:124–131.
Bral, C.M. and Ramos, K.S. (1997). Identification of benzo [a]pyrene-inducible cis-acting elements within c-Ha-ras transcriptional regulatory sequences. Mol. Pharmacol. 52: 974–982.
Lee, W. and Keller, E.B. (1991). Regulatory elements mediating transcription of the human Ha-ras gene. J. Mol. Biol. 220:599–611.
Lu, J., Lee, W., Jiang, C., and Keller, E.B. (1994). Start site selection by Sp1, in the TATA-less human Ha-ras promoter. J. Biol. Chem. 269:5391–5402.
Adelman, K., Marr, M.T., Werner, J., Saunders, A., Ni, Z., Andrulis, E.D., et al. (2005). Efficient release from promoter-proximal stall sites requires transcript cleavage factor TFIIS. Mol. Cell. 17:103–112.
Alves, G., Kawamura, M.T., Nascimento, P., Maciel, C., Oliveira, J.A., Teixeira, A., et al. (2000). DNA release by LINE-1 (L1) retrotransposon. Could it be possible? Ann. NY Acad. Sci. 906:129–133.
Ares, M.P., Porn-Ares, M.I., Moses, S., Thyberg, J., Juntti-Berggren, L., Berggren, P., et al. (2000). 7beta-Hydroxycholesterol induces Ca2+ oscillations, MAP kinase activation and apoptosis in human aortic smooth muscle cells. Atherosclerosis 153:23–35.
Benihoud, K., Bonardelle, D., Soual-Hoebeke, E., Durand-Gasselin, I., Emilie, D., Kiger, N., et al. (2002). Unusual expression of LINE-1 transposable element in the MRL autoimmune lymphoproliferative syndrome-prone strain. Oncogene 21:5593–5600.
Bittinger, M.A., Nguyen, L.P., and Bradfield, C.A. (2003). Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor. Mol. Pharmacol. 64:550–5556.
Bjorkhem, I. and Diczfalusy, U. (2002). Oxysterols: friends, foes, or just fellow passengers? Arterioscler. Thrombs. Vasc. Biol. 22:734–742.
Benson, D.A., Karsch-Mizrachi, I., Lipman, D.J., Ostell, J., Wheeler, D.L.: GenBank: update. Nucleic Acids Res (2004) Jan 1:32 (Database issue): D23–26.
Braam, B., de Roos, R., Bluyssen, H., Kemmeren, P., Holstege, F., Joles, J.A., et al. (2005). Nitric oxide-dependent and nitric oxide-independent transcriptional responses to high shear stress in endothelial cells. Hypertension 45: 672.
Kazazian, H.H.J. and Goodier, J.L. (2002). LINE drive retrotransposition and genome instability. Cell 110:277–280.
Kazazian, H.H.J., Wong, C., Youssoufian, H., Scott, A.F., Phillips, D.G., and Antonarakis, S.E. (1988). Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 332:164–166.
Nangia-Makker, P., Sarvis, R., Visscher, D.W., Bailey-Penrod, J., Raz, A., and Sarkar, R.H. (1998). Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Res. Treat. 49:171–183.
Suter, C.M., Martin, D.I., and Ward, R.L. (2004). Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int. J. Colorectal Dis. 19: 95–101.
Ishihara, H., Tanaka, I., Furuse, M., and Tsuneoka, K. (2000). Increased expression of intracisternal A-particle RNA in regenerated myeloid cells after X irradiation in C3H/He inbred mice. Radiat. Res. 153:392–397.
Ishihara, H. and Tanaka, I. (1997). Detection and cloning of unique integration sites of retrotransposon, intracisternal A-particle element in the genome of acute myeloid leukemia cells in mice. FEBS Lett. 418:205–209.
Lu, K.P. and Ramos, K.S. (1998). Identification of genes differentially expressed in vascular smooth muscle cells following benzo[a]pyrene challenge: implications for chemical atherogenesis. Biochem. Biophys. Res. Commun. 253: 828–833.
Lu, K.P., Hallberg, L.M., Tomlinson, J., and Ramos, K.S. (2000). Benzo(a)pyrene activates L1Md retrotransposon and inhibits DNA repair in vascular smooth muscle cells. Mutat. Res. 454:35–44.
Ikeda, K., Nakayashiki, H., Takagi, M., Tosa, Y., and Mayama, S. (2001). Heat shock, copper sulfate and oxidative stress activate the retrotransposon MAGGY resident in the plant pathogenic fungus Magnaporthe grisea. Mol. Genet. Genomics. 266:318–325.
Mhiri, C. Morel, J.B., Vernhettes, S., Casacuberta, J.M., Lucas, H., and Grandbastien, M.A. (1997). The promoter of the tobacco Tnt1 retrotransposon is induced by wounding and by abiotic stress. Plant Mol. Biol. 33:257–266.
Mears, M.L. and Hutchison, C.A. 3rd. (2001). The evolution of modern lineages of mouse L1 element. J. Mol. Evol. 52:51–62.
Tremblay, A., Jasin, M., and Chartrand, P. (2000). A double-strand break in a chromosomal LINE element can be repaired by gene conversion with various endogenous LINE elements in mouse cells. Mol. Cell. Biol. 20:54–60.
Kazazian, H.H. Jr. (1998). Mobile elements and disease. Curr. Opin. Genet Dev. 8:343–350.
Kidwell, M.G. and Lisch, D. (1997). Transposable elements as sources of variation in animals and plants. Proc. Natl. Acad. Sci. USA 94:7704–7711.
Kingsmore, S.F., Giros, B., Suh, D., Bieniarz, M., Caron, M.G., and Seldin, M.F. (1994). Glycine receptor betasubunit gene mutation in spastic mouse associated with LINE-1 element insertion. Nat. Genet. 7:136–141.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramos, K.S., Partridge, C.R. Atherosclerosis and cancer. Cardiovasc Toxicol 5, 245–255 (2005). https://doi.org/10.1385/CT:5:3:245
Issue Date:
DOI: https://doi.org/10.1385/CT:5:3:245